Publication|Articles|October 21, 2025
- Pharmaceutical Executive: October 2025
- Volume 45
- Issue 8
Pharmaceutical Executive: October 2025 Interactive Digital Edition
View the Pharmaceutical Executive October 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
10 months ago
Price Checks10 months ago
Bob Mauch: Strengthening the Chain10 months ago
Elevate Earned Media Through Continuing EducationAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma
5
